Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2362835
Max Phase: Preclinical
Molecular Formula: C19H17N3O2
Molecular Weight: 319.36
Molecule Type: Small molecule
Associated Items:
ID: ALA2362835
Max Phase: Preclinical
Molecular Formula: C19H17N3O2
Molecular Weight: 319.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N#Cc1cccc(C(=O)C(=O)N2CCN(c3ccccc3)CC2)c1
Standard InChI: InChI=1S/C19H17N3O2/c20-14-15-5-4-6-16(13-15)18(23)19(24)22-11-9-21(10-12-22)17-7-2-1-3-8-17/h1-8,13H,9-12H2
Standard InChI Key: PERZBZUBDTWLMI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 319.36 | Molecular Weight (Monoisotopic): 319.1321 | AlogP: 2.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 64.41 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.42 | CX LogP: 2.73 | CX LogD: 2.73 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.64 | Np Likeness Score: -1.73 |
1. PubChem BioAssay data set, |
Source(1):